ESC 365 - Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study.

Back

ESC Professional Premium Access

Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study.

Session: Risk factors and prevention: epidemiology (2)

Topic: Epidemiology

Speaker: Mrs L. Loennberg (Vasteras, SE)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Mrs Lena Loennberg

Vastmanland County Hospital, Vasteras (Sweden)

0 follower

6 more presentations in this session

Aspirin overuse in primary prevention: nationwide temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in adults with and without diabetes

Speaker: Doctor A. Kristensen (Frederiksberg, DK)

Sex specific lifetime risk of incident cardiovascular events. Results from a large British population-based cohort study.

Speaker: Doctor T. Pana (Aberdeen, GB)

Combined pharmacotherapy in atrial fibrillation patients and their risk of stroke, dementia, and cardiovascular deaths

Speaker: Doctor M. Ding (Stockholm, SE)

Influence of birth weight on later life cardiovascular structure, function and disease: unpacking influences from direct genetic effects versus intrauterine programming

Speaker: Mr A. Morley (Cambridge, GB)

Genetic risk, modifiable risk factors, and atrial fibrillation in the Danish diet, cancer, and health cohort

Speaker: Ms T. Frederiksen (Aarhus, DK)

Access the full session

Risk factors and prevention: epidemiology (2)

Speakers: Mrs L. Loennberg, Doctor A. Kristensen, Doctor T. Pana, Doctor M. Ding, Mr A. Morley...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

Early screening for metabolic syndrome opens a window of opportunity - learnings from a long-term, population-based study.

About the speaker

Mrs Lena Loennberg

6 more presentations in this session

Aspirin overuse in primary prevention: nationwide temporal trends in low-dose aspirin therapy for primary prevention of cardiovascular disease in adults with and without diabetes

Sex specific lifetime risk of incident cardiovascular events. Results from a large British population-based cohort study.

Combined pharmacotherapy in atrial fibrillation patients and their risk of stroke, dementia, and cardiovascular deaths

Influence of birth weight on later life cardiovascular structure, function and disease: unpacking influences from direct genetic effects versus intrauterine programming

Genetic risk, modifiable risk factors, and atrial fibrillation in the Danish diet, cancer, and health cohort

Access the full session

Risk factors and prevention: epidemiology (2)

About the event

ESC Congress 2023

ESC 365 is supported by